Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3743104014 | Tobramycin only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3743105010 | Product containing only tobramycin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4574541000052115 | läkemedel som endast innehåller tobramycin, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobramycin only product in parenteral dose form | Is a | Product containing tobramycin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Tobramycin only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Tobramycin only product in parenteral dose form | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Tobramycin only product in parenteral dose form | Is a | Product containing only tobramycin (medicinal product) | true | Inferred relationship | Some | ||
| Tobramycin only product in parenteral dose form | Has active ingredient | Tobramycin (substance) | true | Inferred relationship | Some | 1 | |
| Tobramycin only product in parenteral dose form | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Tobramycin only product in parenteral dose form | Inferred relationship | Some | |
| Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial | Is a | True | Tobramycin only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely tobramycin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Tobramycin only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR